Welgene Biotech Co (ROCO:6661) FCF Margin % : 19.60% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Welgene Biotech Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Welgene Biotech Co's Free Cash Flow for the three months ended in Dec. 2023 was NT$14.4 Mil. Welgene Biotech Co's Revenue for the three months ended in Dec. 2023 was NT$73.7 Mil. Therefore, Welgene Biotech Co's FCF Margin % for the quarter that ended in Dec. 2023 was 19.60%.

As of today, Welgene Biotech Co's current FCF Yield % is -5.29%.

The historical rank and industry rank for Welgene Biotech Co's FCF Margin % or its related term are showing as below:

ROCO:6661' s FCF Margin % Range Over the Past 10 Years
Min: -10.02 Med: 4.72 Max: 18.33
Current: -10.02

During the past 10 years, the highest FCF Margin % of Welgene Biotech Co was 18.33%. The lowest was -10.02%. And the median was 4.72%.

ROCO:6661's FCF Margin % is ranked better than
50.68% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.54 vs ROCO:6661: -10.02

Welgene Biotech Co FCF Margin % Historical Data

The historical data trend for Welgene Biotech Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Welgene Biotech Co FCF Margin % Chart

Welgene Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

18.33

9.01

2.20

7.63

-10.02

Welgene Biotech Co Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															0.99	-11.63	-23.83	-22.87	19.60

Competitive Comparison of Welgene Biotech Co's FCF Margin %

For the Diagnostics & Research subindustry, Welgene Biotech Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Welgene Biotech Co's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Welgene Biotech Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Welgene Biotech Co's FCF Margin % falls into.

Welgene Biotech Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Welgene Biotech Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-28.1	/	280.547
	=	-10.02 %

Welgene Biotech Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	14.438	/	73.656
	=	19.60 %

Welgene Biotech Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Welgene Biotech Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Welgene Biotech Co (ROCO:6661) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Welgene Biotech Co Ltd (ROCO:6661) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Yuanqu Street, 12th Floor, Nangang District, Taipei, TWN, 115

Website

https://www.welgene.com.tw

Welgene Biotech Co Ltd is engaged in providing clinical testing service. It service and products offerings include next-generation sequencing service, microarray service, OPS diagnostics products, and Biovesicle products. The company also offers clinical testing agents and instruments.

Welgene Biotech Co (ROCO:6661) Headlines

No Headlines